US Stock MarketDetailed Quotes

FATE Fate Therapeutics

Watchlist
  • 1.830
  • -0.095-4.94%
Close Dec 13 16:00 ET
  • 1.950
  • +0.120+6.55%
Post 19:58 ET
208.43MMarket Cap-1.12P/E (TTM)

Fate Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
23.13%-29.42M
-13.38%-32.31M
-15.56%-33.35M
46.71%-132.26M
51.40%-36.64M
30.47%-38.27M
46.40%-28.49M
55.33%-28.86M
-52.40%-248.21M
-7.25%-75.39M
Net income from continuing operations
-5.55%-47.68M
27.16%-38.43M
-154.25%-48M
42.88%-160.93M
21.72%-44.12M
45.94%-45.17M
30.68%-52.76M
71.26%-18.88M
-32.79%-281.72M
17.86%-56.36M
Depreciation and amortization
-2.81%4.61M
5.71%4.72M
15.03%4.82M
32.88%18.28M
0.89%4.89M
48.45%4.74M
50.78%4.47M
51.79%4.19M
135.18%13.76M
119.49%4.84M
Other non cash items
100.70%13K
59.15%-1.72M
102.48%869K
-70.16%-40.86M
102.32%220K
51.58%-1.87M
-5,485.90%-4.2M
-225.31%-35.01M
-32.68%-24.01M
-41.76%-9.47M
Change In working capital
210.88%3.13M
-127.00%-3.79M
-94.95%614K
155.26%19.18M
87.13%-4.19M
-127.86%-2.82M
1,309.30%14.04M
209.22%12.15M
-1,754.43%-34.71M
-152.99%-32.55M
-Change in receivables
-291.28%-2.48M
-101.30%-190K
-95.39%968K
222.98%36.65M
98.98%-288K
-55.36%1.3M
1,925.69%14.67M
505.49%20.98M
-843.16%-29.8M
-1,970.11%-28.26M
-Change in prepaid assets
387.78%4.22M
-185.55%-3.49M
-61.64%4.57M
170.25%12.88M
77.91%-1.64M
47.45%-1.47M
171.15%4.08M
594.43%11.9M
-500.59%-18.33M
-554.82%-7.41M
-Change in payables and accrued expense
182.03%1.87M
107.32%320K
77.90%-4.51M
-303.06%-28.94M
-155.89%-1.89M
-122.19%-2.28M
-207.21%-4.37M
-483.82%-20.39M
141.27%14.25M
132.63%3.39M
-Change in other working capital
-29.38%-480K
-31.91%-434K
-22.62%-412K
-70.05%-1.41M
-37.27%-372K
-37.41%-371K
-40.00%-329K
-546.15%-336K
-134.46%-828K
-2,563.64%-271K
Cash from discontinued investing activities
Operating cash flow
23.13%-29.42M
-13.38%-32.31M
-15.56%-33.35M
46.71%-132.26M
51.40%-36.64M
30.47%-38.27M
46.40%-28.49M
55.33%-28.86M
-52.40%-248.21M
-7.25%-75.39M
Investing cash flow
Cash flow from continuing investing activities
2.64%25.46M
-260.92%-53.37M
85.37%17.31M
-32.44%112.67M
-14.61%45.35M
-69.14%24.81M
-17.67%33.17M
232.93%9.34M
151.46%166.75M
-25.49%53.11M
Net PPE purchase and sale
12.39%-495K
97.68%-51K
97.32%-86K
82.70%-6.15M
97.29%-181K
93.49%-565K
78.29%-2.2M
68.19%-3.21M
29.86%-35.57M
63.65%-6.68M
Net investment purchase and sale
2.31%25.96M
-250.77%-53.32M
38.67%17.4M
-41.27%118.82M
-23.84%45.53M
-71.51%25.37M
-29.85%35.37M
310.33%12.55M
174.02%202.32M
-33.31%59.79M
Cash from discontinued investing activities
Investing cash flow
2.64%25.46M
-260.92%-53.37M
85.37%17.31M
-32.44%112.67M
-14.61%45.35M
-69.14%24.81M
-17.67%33.17M
232.93%9.34M
151.46%166.75M
-25.49%53.11M
Financing cash flow
Cash flow from continuing financing activities
0
2,096.55%1.27M
46,029.47%95.49M
-99.08%85K
-111.87%-180K
0
-98.30%58K
-92.60%207K
-97.97%9.21M
-55.62%1.52M
Net common stock issuance
--0
---662K
--75.19M
----
----
--0
--0
--0
----
----
Proceeds from stock option exercised by employees
--0
-106.90%-4K
9,704.35%20.3M
-99.08%85K
-111.87%-180K
--0
-98.30%58K
-92.60%207K
-77.76%9.21M
-56.02%1.52M
Net other financing activities
--0
----
----
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
--0
2,096.55%1.27M
46,029.47%95.49M
-99.08%85K
-111.87%-180K
--0
-98.30%58K
-92.60%207K
-97.97%9.21M
-55.62%1.52M
Net cash flow
Beginning cash position
-15.95%52.09M
138.44%136.5M
-25.49%57.05M
-48.55%76.56M
-50.15%48.51M
-12.09%61.98M
-28.41%57.25M
-48.55%76.56M
-18.49%148.81M
-32.61%97.32M
Current changes in cash
70.61%-3.96M
-1,883.71%-84.41M
511.39%79.45M
72.99%-19.51M
141.12%8.54M
-150.22%-13.47M
149.99%4.73M
71.95%-19.31M
-113.99%-72.25M
-571.50%-20.76M
End cash Position
-0.77%48.14M
-15.95%52.09M
138.44%136.5M
-25.49%57.05M
-25.49%57.05M
-50.15%48.51M
-12.09%61.98M
-28.41%57.25M
-48.55%76.56M
-48.55%76.56M
Free cash flow
22.98%-29.91M
-5.42%-32.36M
-4.27%-33.44M
51.22%-138.42M
55.14%-36.82M
39.05%-38.84M
51.50%-30.69M
57.07%-32.07M
-32.87%-283.77M
7.44%-82.07M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 23.13%-29.42M-13.38%-32.31M-15.56%-33.35M46.71%-132.26M51.40%-36.64M30.47%-38.27M46.40%-28.49M55.33%-28.86M-52.40%-248.21M-7.25%-75.39M
Net income from continuing operations -5.55%-47.68M27.16%-38.43M-154.25%-48M42.88%-160.93M21.72%-44.12M45.94%-45.17M30.68%-52.76M71.26%-18.88M-32.79%-281.72M17.86%-56.36M
Depreciation and amortization -2.81%4.61M5.71%4.72M15.03%4.82M32.88%18.28M0.89%4.89M48.45%4.74M50.78%4.47M51.79%4.19M135.18%13.76M119.49%4.84M
Other non cash items 100.70%13K59.15%-1.72M102.48%869K-70.16%-40.86M102.32%220K51.58%-1.87M-5,485.90%-4.2M-225.31%-35.01M-32.68%-24.01M-41.76%-9.47M
Change In working capital 210.88%3.13M-127.00%-3.79M-94.95%614K155.26%19.18M87.13%-4.19M-127.86%-2.82M1,309.30%14.04M209.22%12.15M-1,754.43%-34.71M-152.99%-32.55M
-Change in receivables -291.28%-2.48M-101.30%-190K-95.39%968K222.98%36.65M98.98%-288K-55.36%1.3M1,925.69%14.67M505.49%20.98M-843.16%-29.8M-1,970.11%-28.26M
-Change in prepaid assets 387.78%4.22M-185.55%-3.49M-61.64%4.57M170.25%12.88M77.91%-1.64M47.45%-1.47M171.15%4.08M594.43%11.9M-500.59%-18.33M-554.82%-7.41M
-Change in payables and accrued expense 182.03%1.87M107.32%320K77.90%-4.51M-303.06%-28.94M-155.89%-1.89M-122.19%-2.28M-207.21%-4.37M-483.82%-20.39M141.27%14.25M132.63%3.39M
-Change in other working capital -29.38%-480K-31.91%-434K-22.62%-412K-70.05%-1.41M-37.27%-372K-37.41%-371K-40.00%-329K-546.15%-336K-134.46%-828K-2,563.64%-271K
Cash from discontinued investing activities
Operating cash flow 23.13%-29.42M-13.38%-32.31M-15.56%-33.35M46.71%-132.26M51.40%-36.64M30.47%-38.27M46.40%-28.49M55.33%-28.86M-52.40%-248.21M-7.25%-75.39M
Investing cash flow
Cash flow from continuing investing activities 2.64%25.46M-260.92%-53.37M85.37%17.31M-32.44%112.67M-14.61%45.35M-69.14%24.81M-17.67%33.17M232.93%9.34M151.46%166.75M-25.49%53.11M
Net PPE purchase and sale 12.39%-495K97.68%-51K97.32%-86K82.70%-6.15M97.29%-181K93.49%-565K78.29%-2.2M68.19%-3.21M29.86%-35.57M63.65%-6.68M
Net investment purchase and sale 2.31%25.96M-250.77%-53.32M38.67%17.4M-41.27%118.82M-23.84%45.53M-71.51%25.37M-29.85%35.37M310.33%12.55M174.02%202.32M-33.31%59.79M
Cash from discontinued investing activities
Investing cash flow 2.64%25.46M-260.92%-53.37M85.37%17.31M-32.44%112.67M-14.61%45.35M-69.14%24.81M-17.67%33.17M232.93%9.34M151.46%166.75M-25.49%53.11M
Financing cash flow
Cash flow from continuing financing activities 02,096.55%1.27M46,029.47%95.49M-99.08%85K-111.87%-180K0-98.30%58K-92.60%207K-97.97%9.21M-55.62%1.52M
Net common stock issuance --0---662K--75.19M----------0--0--0--------
Proceeds from stock option exercised by employees --0-106.90%-4K9,704.35%20.3M-99.08%85K-111.87%-180K--0-98.30%58K-92.60%207K-77.76%9.21M-56.02%1.52M
Net other financing activities --0------------------------------------
Cash from discontinued financing activities
Financing cash flow --02,096.55%1.27M46,029.47%95.49M-99.08%85K-111.87%-180K--0-98.30%58K-92.60%207K-97.97%9.21M-55.62%1.52M
Net cash flow
Beginning cash position -15.95%52.09M138.44%136.5M-25.49%57.05M-48.55%76.56M-50.15%48.51M-12.09%61.98M-28.41%57.25M-48.55%76.56M-18.49%148.81M-32.61%97.32M
Current changes in cash 70.61%-3.96M-1,883.71%-84.41M511.39%79.45M72.99%-19.51M141.12%8.54M-150.22%-13.47M149.99%4.73M71.95%-19.31M-113.99%-72.25M-571.50%-20.76M
End cash Position -0.77%48.14M-15.95%52.09M138.44%136.5M-25.49%57.05M-25.49%57.05M-50.15%48.51M-12.09%61.98M-28.41%57.25M-48.55%76.56M-48.55%76.56M
Free cash flow 22.98%-29.91M-5.42%-32.36M-4.27%-33.44M51.22%-138.42M55.14%-36.82M39.05%-38.84M51.50%-30.69M57.07%-32.07M-32.87%-283.77M7.44%-82.07M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Heat List
US
Overall
Symbol
Price
% Chg

No Data